Human anti-idiotypic antibodies can be good immunogens as they target Fc receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responses

被引:18
作者
Durrant, LG
Parsons, T
Moss, R
Spendlove, I
Carter, G
Carr, F
机构
[1] Univ Nottingham, City Hosp, CRC, Acad Unit Clin Oncol, Nottingham NG5 1PB, England
[2] Biovat Ltd, Aberdeen, Scotland
关键词
tumour vaccines; helper T-cell responses; blastogenesis; anti-idiotypes; peptides;
D O I
10.1002/ijc.1194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anti-idiotypic antibodies that mimic tumour-associated antigens can stimulate anti-tumour T-cell responses. In this article, we have studied the role of pc in the presentation of T-cell epitopes by 2 anti-idiotypic antibodies, 105AD7 and 708, The human monoclonal antibody 105AD7, which mimics CD55, stimulated strong in vitro T-cell proliferation, gamma IFN secretion and redirected cytotoxicity in unprimed T cells from healthy donors. However, removal of the pc region of the anti-idiotype reduced the sensitivity of the assay 1,000-fold, as did inhibiting Fc uptake of the anti-idiotype by an excess of human IgG. The mouse anti-idiotype 708, which mimics CEA, failed to stimulate in vitro T-cell responses on unprimed T cells from healthy donors. However, when a human IgGI pc region replaced its mouse pc region, the anti-idiotype induced T-cell proliferation, gamma IFN secretion and redirected cytotoxicity in lymphocytes from unimmunised donors. Human anti-idiotypes are therefore good immunogens since they target pc receptors on antigen-presenting cells, allowing efficient stimulation of both helper and cytotoxic T-cell responses. The immunogenicity of other antiidiotypes may therefore be enhanced by human pc targeting of antigen-presenting cells. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:414 / 420
页数:7
相关论文
共 19 条
[1]  
AMIN S, 2000, IN PRESS CANC RES
[2]   INDUCTION OF DELAYED-HYPERSENSITIVITY TO HUMAN TUMOR-CELLS WITH A HUMAN MONOCLONAL ANTIIDIOTYPIC ANTIBODY [J].
AUSTIN, EB ;
ROBINS, RA ;
BALDWIN, RW ;
DURRANT, LG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (17) :1245-1248
[3]  
AUSTIN EB, 1989, IMMUNOLOGY, V67, P525
[4]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[5]   SPECIFICITY AND PROMISCUITY AMONG NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR ALLELES [J].
CHICZ, RM ;
URBAN, RG ;
GORGA, JC ;
VIGNALI, DAA ;
LANE, WS ;
STROMINGER, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) :27-47
[6]   CLINICAL OUTCOME OF COLORECTAL-CANCER PATIENTS TREATED WITH HUMAN MONOCLONAL ANTIIDIOTYPIC ANTIBODY [J].
DENTON, GWL ;
DURRANT, LG ;
HARDCASTLE, JD ;
AUSTIN, EB ;
SEWELL, HF ;
ROBINS, RA .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (01) :10-14
[7]  
Durrant LG, 2000, CLIN CANCER RES, V6, P422
[8]  
Durrant LG, 2000, INT J CANCER, V85, P87, DOI 10.1002/(SICI)1097-0215(20000101)85:1<87::AID-IJC16>3.0.CO
[9]  
2-K
[10]   AN IDIOTYPIC REPLICA OF CARCINOEMBRYONIC ANTIGEN INDUCING CELLULAR AND HUMORAL RESPONSES DIRECTED AGAINST HUMAN COLORECTAL TUMORS [J].
DURRANT, LG ;
DENTON, GWL ;
JACOBS, E ;
MEE, M ;
MOSS, R ;
AUSTIN, EB ;
BALDWIN, RW ;
HARDCASTLE, JD ;
ROBINS, RA .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (05) :811-816